• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI 前列腺外延伸分级:评估前列腺外肿瘤的准确性和临床附加价值。

MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer.

机构信息

Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.

Department of Radiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.

出版信息

Biomed Res Int. 2022 Aug 30;2022:3203965. doi: 10.1155/2022/3203965. eCollection 2022.

DOI:10.1155/2022/3203965
PMID:36082151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9448588/
Abstract

OBJECTIVE

The purpose was to compare the accuracy of extraprostatic extension (EPE) grade on MRI predicting EPE with Partin tables, Memorial Sloan Kettering Cancer Center nomogram (MSKCCn), and combined models and to analyze the clinical incremental value of EPE grade.

MATERIALS AND METHODS

105 prostate cancer patients confirmed by pathology after radical prostatectomy in our hospital from 2017 to 2021 were selected. The clinical stage, PSA, Gleason score, number of positive biopsy cores, and percentage of positive biopsy cores were recorded. Evaluate EPE grade according to EPE grade criteria, and calculate the probability of predicting EPE with Partin tables and MSKCCn. EPE grade is combined with Partin tables and MSKCCn to construct EPE grade+Partin tables and EPE grade+MSKCCn models. Calculate the area under the curve (AUC), sensitivity, and specificity of EPE grade, Partin tables, MSKCCn, EPE grade+Partin tables, and EPE grade+MSKCCn and compare their diagnostic efficacy. The clinical decision curve was used to analyze the clinical net income of each prediction scheme.

RESULTS

The AUC of EPE grade was 0.79, Partin tables was 0.50, MSKCCn was 0.78, the EPE grade+Partin table model was 0.79, and the EPE grade+MSKCCn model was 0.83. After EPE grade was combined with Partin tables and MSKCCn, the diagnostic efficiency of clinical model was significantly improved ( < 0.05). There was no significant difference in the diagnostic efficacy of the combined model compared with the single EPE grade ( > 0.05). The calibration curve of the combined model shows that it has a good calibration degree for EPE. In the analysis of the decision curve, the net income of the EPE grade is higher than that of Partin tables and MSKCCn and is equal to the EPE grade+Partin tables and is slightly lower than that of EPE grade+MSKCCn. The clinical net income of the combined model is obviously higher than that of individual clinical models.

CONCLUSION

The accuracy of EPE classification in predicting prostate cancer EPE is high, and combined with the clinical model, it can significantly improve the diagnostic efficiency of the clinical model and increase the clinical benefit.

摘要

目的

比较 MRI 上前列腺癌外扩程度(EPE)分级预测 EPE 的准确性,与 Partin 表、 Memorial Sloan Kettering 癌症中心列线图(MSKCCn)和联合模型进行比较,并分析 EPE 分级的临床增量价值。

材料和方法

选取我院 2017 年至 2021 年经根治性前列腺切除术后病理证实的 105 例前列腺癌患者,记录临床分期、PSA、Gleason 评分、阳性活检核心数及阳性活检核心百分比。按 EPE 分级标准评估 EPE 分级,并计算 Partin 表和 MSKCCn 预测 EPE 的概率。将 EPE 分级与 Partin 表和 MSKCCn 相结合,构建 EPE 分级+Partin 表和 EPE 分级+MSKCCn 模型。计算 EPE 分级、Partin 表、MSKCCn、EPE 分级+Partin 表和 EPE 分级+MSKCCn 的曲线下面积(AUC)、敏感度和特异度,并比较其诊断效能。采用临床决策曲线分析各预测方案的临床净收益。

结果

EPE 分级的 AUC 为 0.79,Partin 表为 0.50,MSKCCn 为 0.78,EPE 分级+Partin 表模型为 0.79,EPE 分级+MSKCCn 模型为 0.83。EPE 分级与 Partin 表和 MSKCCn 结合后,临床模型的诊断效能明显提高(<0.05)。与单一 EPE 分级相比,联合模型的诊断效能差异无统计学意义(>0.05)。联合模型的校准曲线表明,其对 EPE 具有良好的校准程度。在决策曲线分析中,EPE 分级的净收益高于 Partin 表和 MSKCCn,与 EPE 分级+Partin 表相当,略低于 EPE 分级+MSKCCn。联合模型的临床净收益明显高于单一临床模型。

结论

EPE 分级预测前列腺癌 EPE 的准确性较高,与临床模型相结合,可显著提高临床模型的诊断效能,增加临床获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/48b1e0e33a2a/BMRI2022-3203965.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/2a517212e54c/BMRI2022-3203965.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/1443d16d9a8d/BMRI2022-3203965.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/f7816a09f47b/BMRI2022-3203965.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/48b1e0e33a2a/BMRI2022-3203965.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/2a517212e54c/BMRI2022-3203965.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/1443d16d9a8d/BMRI2022-3203965.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/f7816a09f47b/BMRI2022-3203965.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/9448588/48b1e0e33a2a/BMRI2022-3203965.004.jpg

相似文献

1
MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer.MRI 前列腺外延伸分级:评估前列腺外肿瘤的准确性和临床附加价值。
Biomed Res Int. 2022 Aug 30;2022:3203965. doi: 10.1155/2022/3203965. eCollection 2022.
2
External Validation of the Extraprostatic Extension Grade on MRI and Its Incremental Value to Clinical Models for Assessing Extraprostatic Cancer.MRI 上前列腺外侵犯分级的外部验证及其对评估前列腺外癌临床模型的增量价值。
Front Oncol. 2021 Apr 1;11:655093. doi: 10.3389/fonc.2021.655093. eCollection 2021.
3
Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.多参数 MRI、Partin 表、纪念斯隆-凯特琳癌症中心列线图和 CAPRA 评分在预测接受根治性前列腺切除术患者前列腺外癌中的头对头比较。
J Magn Reson Imaging. 2019 Nov;50(5):1604-1613. doi: 10.1002/jmri.26743. Epub 2019 Apr 7.
4
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.联合临床参数和多参数磁共振成像预测前列腺外疾病-用于计划根治性前列腺切除术时患者个体化风险分层的风险模型。
Eur Urol Focus. 2020 Nov 15;6(6):1205-1212. doi: 10.1016/j.euf.2018.11.004. Epub 2018 Nov 23.
5
Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?将多参数 MRI 添加到 MSKCC 和 Partin 前列腺癌原发肿瘤列线图中:是否能改善局部肿瘤分期?
Urol Oncol. 2019 Mar;37(3):181.e1-181.e6. doi: 10.1016/j.urolonc.2018.10.026. Epub 2018 Dec 15.
6
Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.基于临床分期、血清前列腺特异性抗原和活检Gleason评分预测病理分期:当代的Partin表
BJU Int. 2017 May;119(5):676-683. doi: 10.1111/bju.13573. Epub 2016 Jul 29.
7
Reliability of the different versions of Partin tables in predicting extraprostatic extension of prostate cancer: a systematic review and meta-analysis.帕廷表不同版本在预测前列腺癌前列腺外侵犯方面的可靠性:一项系统评价和荟萃分析。
Minerva Urol Nefrol. 2019 Oct;71(5):457-478. doi: 10.23736/S0393-2249.19.03427-1. Epub 2019 Apr 5.
8
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.前列腺 MRI 加入 CAPRA、MSKCC 和 Partin 癌症列线图可显著提高根治性前列腺切除术后不良发现和生化复发的预测能力。
PLoS One. 2020 Jul 9;15(7):e0235779. doi: 10.1371/journal.pone.0235779. eCollection 2020.
9
Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.前列腺癌前列腺外侵犯预测模型的诊断性能:一项系统评价和荟萃分析
Insights Imaging. 2023 Aug 22;14(1):140. doi: 10.1186/s13244-023-01486-7.
10
Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.使用2005年国际泌尿病理学会关于Gleason分级的共识,对日本临床局限性前列腺癌患者进行Partin表验证及术前列线图的开发:来自局限性前列腺癌临床病理研究组的数据
J Urol. 2008 Sep;180(3):904-9; discussion 909-10. doi: 10.1016/j.juro.2008.05.047. Epub 2008 Jul 17.

引用本文的文献

1
Development and validation of a novel clinical-radiological-pathological scoring system for preoperative prediction of extraprostatic extension in prostate cancer: a multicenter retrospective study.一种用于术前预测前列腺癌前列腺外侵犯的新型临床-放射-病理评分系统的开发与验证:一项多中心回顾性研究
Cancer Imaging. 2025 Jul 1;25(1):83. doi: 10.1186/s40644-025-00905-w.
2
Preoperative multidisciplinary team meeting improves the incidence of positive margins in pathological T2 prostate cancer.术前多学科团队会议可提高病理 T2 期前列腺癌中阳性切缘的发生率。
World J Urol. 2024 Oct 9;42(1):571. doi: 10.1007/s00345-024-05261-1.
3

本文引用的文献

1
Diagnostic Performance of Extraprostatic Extension Grading System for Detection of Extraprostatic Extension in Prostate Cancer: A Diagnostic Systematic Review and Meta-Analysis.前列腺癌前列腺外侵犯分级系统检测前列腺外侵犯的诊断性能:一项诊断性系统评价与Meta分析
Front Oncol. 2022 Jan 25;11:792120. doi: 10.3389/fonc.2021.792120. eCollection 2021.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
External Validation of the Extraprostatic Extension Grade on MRI and Its Incremental Value to Clinical Models for Assessing Extraprostatic Cancer.
Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.
前列腺癌前列腺外侵犯预测模型的诊断性能:一项系统评价和荟萃分析
Insights Imaging. 2023 Aug 22;14(1):140. doi: 10.1186/s13244-023-01486-7.
4
Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study.基于磁共振成像的联合放射组学-临床模型预测前列腺癌包膜外侵犯的价值:一项初步研究
Transl Cancer Res. 2023 Jul 31;12(7):1787-1801. doi: 10.21037/tcr-22-2750. Epub 2023 Jun 26.
5
The Diagnostic Performance of Tumor Stage on MRI for Predicting Prostate Cancer-Positive Surgical Margins: A Systematic Review and Meta-Analysis.MRI上肿瘤分期对预测前列腺癌手术切缘阳性的诊断性能:一项系统评价和荟萃分析。
Diagnostics (Basel). 2023 Jul 27;13(15):2497. doi: 10.3390/diagnostics13152497.
MRI 上前列腺外侵犯分级的外部验证及其对评估前列腺外癌临床模型的增量价值。
Front Oncol. 2021 Apr 1;11:655093. doi: 10.3389/fonc.2021.655093. eCollection 2021.
4
Assessing Extraprostatic Extension with Multiparametric MRI of the Prostate: Mehralivand Extraprostatic Extension Grade or Extraprostatic Extension Likert Scale?评估前列腺多参数 MRI 的前列腺外延伸:Mehralivand 前列腺外延伸分级还是前列腺外延伸 Likert 量表?
Radiol Imaging Cancer. 2020 Jan 17;2(1):e190071. doi: 10.1148/rycan.2019190071. eCollection 2020 Jan.
5
Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.前列腺外肿瘤侵犯:根治性前列腺切除术前多参数 MRI 标准与术后组织病理学相关性比较。
Radiology. 2020 Jul;296(1):87-95. doi: 10.1148/radiol.2020192133. Epub 2020 May 5.
6
Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis.多参数磁共振成像检测前列腺癌囊外扩展的准确性:系统评价和荟萃分析。
Br J Radiol. 2019 Dec;92(1104):20190480. doi: 10.1259/bjr.20190480. Epub 2019 Oct 16.
7
Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.多参数 MRI、Partin 表、纪念斯隆-凯特琳癌症中心列线图和 CAPRA 评分在预测接受根治性前列腺切除术患者前列腺外癌中的头对头比较。
J Magn Reson Imaging. 2019 Nov;50(5):1604-1613. doi: 10.1002/jmri.26743. Epub 2019 Apr 7.
8
A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.前列腺癌多参数 MRI 外生评估风险的分级系统。
Radiology. 2019 Mar;290(3):709-719. doi: 10.1148/radiol.2018181278. Epub 2019 Jan 22.
9
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.多参数磁共振成像对临床列线图预测前列腺癌不良病理的增值作用。
J Urol. 2018 Nov;200(5):1041-1047. doi: 10.1016/j.juro.2018.05.094. Epub 2018 May 29.
10
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.第八版泌尿生殖系统癌症肿瘤-淋巴结-转移分期分类更新。
Eur Urol. 2018 Apr;73(4):560-569. doi: 10.1016/j.eururo.2017.12.018. Epub 2018 Jan 9.